ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
120.269,31
-0,67%
S&P 500
5.970,84
-1,11%
US Dollar vs BRL
6,19575
0,00%
Bitcoin
94.905,99
-0,25%
Brent Oil
73,44
0,00%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Sunesis Pharmaceuticals Inc (SNSS)

  7. Sunesis Pharmaceuticals Inc (SNSS) Notícias

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNSS
DataHoraFonteTítuloCódigoCompanhia
09/06/202319:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/05/202317:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/05/202317:53Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/04/202317:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/04/202317:09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/03/202318:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/02/202308:03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/01/202319:22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/11/202218:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
19/09/202219:54Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/07/202217:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SNSSSunesis Pharmaceuticals Inc
27/06/202217:37Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:SNSSSunesis Pharmaceuticals Inc
01/12/202108:08Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:SNSSSunesis Pharmaceuticals Inc
16/02/202118:05Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:SNSSSunesis Pharmaceuticals Inc
15/01/202108:24Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SNSSSunesis Pharmaceuticals Inc
14/01/202119:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SNSSSunesis Pharmaceuticals Inc
13/01/202108:03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:SNSSSunesis Pharmaceuticals Inc
16/11/202018:05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
09/11/202009:00GlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent H...NASDAQ:SNSSSunesis Pharmaceuticals Inc
12/10/202008:00GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular ...NASDAQ:SNSSSunesis Pharmaceuticals Inc
03/09/202008:00GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Participation at Upcoming Investor ConferencesNASDAQ:SNSSSunesis Pharmaceuticals Inc
02/09/202013:48GlobeNewswire Inc.Sunesis Pharmaceuticals Announces 1-for-10 Reverse Stock SplitNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/08/202017:05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
04/08/202008:00GlobeNewswire Inc.Sunesis Pharmaceuticals to Host Conference Call on August 11th to Discuss Second Quarter 2020 Financial Results and Recent Hi...NASDAQ:SNSSSunesis Pharmaceuticals Inc
30/07/202019:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
29/07/202010:05GlobeNewswire Inc.Sunesis Announces Pricing of $12 Million Offering of Common StockNASDAQ:SNSSSunesis Pharmaceuticals Inc
28/07/202017:07GlobeNewswire Inc.Sunesis Announces Proposed Public Offering of Common StockNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/07/202017:01GlobeNewswire Inc.Sunesis Pharmaceuticals Provides Corporate UpdateNASDAQ:SNSSSunesis Pharmaceuticals Inc
23/06/202008:30GlobeNewswire Inc.Sunesis Pharmaceuticals Announces Clinical Update on Vecabrutinib ProgramNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/202017:05GlobeNewswire Inc.Sunesis Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SNSS

Seu Histórico Recente

BIT
U58831
IT0005588311 20290507 16...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados